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Abstract
Caprine brucellosis is a chronic infectious disease caused by the gram-negative cocci-bacil-
lus Brucella melitensis. Middle- to late-term abortion, stillbirths, and the delivery of weak off-
spring are the characteristic clinical signs of the disease that is associated with an extensive
negative impact in a flock’s productivity. B. melitensis is also the most virulent Brucella spe-
cies for humans, responsible for a severely debilitating and disabling illness that results in
high morbidity with intermittent fever, chills, sweats, weakness, myalgia, abortion, osteoarti-
cular complications, endocarditis, depression, anorexia, and low mortality. Historical obser-
vations indicate that goats have been the hosts of B. melitensis for centuries; but around
1905, the Greek physician Themistokles Zammit was able to build the epidemiological link
between “Malta fever” and the consumption of goat milk. While the disease has been suc-
cessfully managed in most industrialized countries, it remains a significant burden on goat
and human health in the Mediterranean region, the Middle East, Central and Southeast Asia
(including India and China), sub-Saharan Africa, and certain areas in Latin America, where
approximately 3.5 billion people live at risk. In this review, we describe a historical evolution
of the disease, highlight the current worldwide distribution, and estimate (by simple formula)
the approximate costs of brucellosis outbreaks to meat- and milk-producing farms and the
economic losses associated with the disease in humans. Successful control leading to erad-
ication of caprine brucellosis in the developing world will require a coordinated Global One
Health approach involving active involvement of human and animal health efforts to
enhance public health and improve livestock productivity.
Author summary
Human brucellosis is an ancient disease that has had different names throughout time
based on the main clinical symptom (fever) and the geographical location: Malta fever,
Mediterranean fever, Undulant fever, Gibraltar fever, Rock fever, and Neapolitan fever,
among others. Retrospective studies have demonstrated that goats have been the hosts of
B. melitensis for centuries, with evidence of its zoonotic potential early in evolution. Since
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domestication of goats (and also sheep), the incidence of human brucellosis has been on
the rise, becoming endemic in resource-limited settings. Today, millions of goats and
approximately half of the human population worldwide live at risk. For that reason, more
effective prevention and control measures, such as affordable vaccines, more sensitive and
specific diagnostic techniques, and the control livestock movement, among others, are
desperately needed to control and eradicate brucellosis in goats and to prevent human
brucellosis.
Introduction
Brucella melitensis is the etiological agent of caprine brucellosis, an infectious zoonotic disease
with significant economic impact on both the livestock industry and public health. Worldwide,
there are approximately 1 billion goats, with an increase of the population by more than 20%
in the last 10 years. Approximately 90% of goats are located in the developing world, where
they are considered one of the most important sources of protein for humans [1]. Caprine bru-
cellosis has been controlled in most industrialized countries; however, this disease remains
endemic in resource-limited settings, where small ruminants are the major livestock species
and the main economical livelihood, such as the Mediterranean region, the Middle East, Cen-
tral Asia, sub-Saharan Africa, and parts of Latin America [2]. Among the different Brucella
spp. capable of causing disease in humans (B. abortus, B. melitensis, B. canis and B. suis), B.
melitensis is the most virulent [3]. Human brucellosis has had different names throughout
time based on the main clinical symptom (fever) and the geographical location: Malta fever,
Mediterranean fever, Undulant fever, Gibraltar fever, Rock fever, and Neapolitan fever, among
others [4]. Brucellosis is considered a severely debilitating and disabling illness that results in
high morbidity with intermittent fever, chills, sweats, weakness, myalgia, abortion, osteoarticu-
lar complications, endocarditis, depression anorexia, and low mortality. Due to causing a pro-
tracted, incapacitating disease with minimal mortality, the low infectivity dose required to
cause infection (10–100 colony-forming units), and the potential for aerosol dissemination, B.
melitensis was considered a potential bioterrorist agent early in the 20th century [5]. Gradually,
biological warfare moved on, and Brucella’s perceived status as a potential agent of bioterror-
ism declined, until the World Trade Center attack in 2001 brought bioterrorism back to the
public’s attention. Nowadays, B. melitensis possession and use is still strictly regulated in the
United States of America, Canada, and some European countries. Conversely, more than half
a million new brucellosis cases per year occur naturally in the populations of developing areas
of the world, a number which is thought to be severely underestimated [6].
Methods
A MEDLINE (via Pubmed) and SCOPUS online databases search for articles with “Brucella
melitensis” or “brucellosis” and “goats” or “small ruminants” as keywords with no date limit
and published up to December 31st, 2016, was performed. An additional internet search was
done in Google without language restriction, using those terms and including country names.
Early reports were obtained from original printouts from the reference list of selected articles
and printed books.
Historical evolution
Despite the first scientific evidence that goats were the reservoir host of B. melitensis in 1905,
several observations would indicate that goats have been the host of B. melitensis for centuries
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[7]. Phylogenetic studies suggest that brucellosis in goats emerged in the past 86,000 to 296,000
years through contact with infected sheep [8]. Interestingly, to support this observation, a
recent study found lesions in vertebral bodies of an Australopithecus africanus (who lived 2.5
million years ago) consistent with brucellosis, where the source of infection could be the con-
sumption of infected tissues from wild animals [9]. Subsequently, the closer association of
humans with goats (and also sheep) due to domestication around 10,000 years ago [10] favored
an increase in the incidence of human brucellosis. As essential resources for human survival,
goat and sheep herds moved along with human communities from the Fertile Crescent in
Southwestern Asia to lands around the Mediterranean Sea [11], where Phoenician traders
might have contributed to the spread of B. melitensis infection throughout the Mediterranean
littoral and islands during the first millennium B.C. [12]; it was then introduced to the Ameri-
cas around the 16th century by Spanish and Portuguese conquerors [11,13].
The first written evidence of goat brucellosis could be inferred from the first description of
2 human cases of brucellosis. In the 4th century B.C., in his Epidemics book, Hippocrates II
described 2 cases of a 120-day fever in people living in the Mediterranean littoral, most likely
associated with the consumption of raw milk or derivatives of B. melitensis-infected sheep or
goats [14]. Another testimony of the ancient presence of caprine brucellosis comes from pre-
served evidence from the volcanic eruption of Mount Vesuvius in Italy on August 25th in the
year 79 A.D. Scanning electron microscopy examination of remnants of carbonized cheeses
revealed cocci-like forms consistent with B. melitensis, while an anthropological examination
of human skeletal remains from that incident revealed an arthritic condition consistent with
brucellosis [7]. References to and vivid descriptions of clinical cases compatible with human
brucellosis were continuously reported in histories of military campaigns and hospital reports
[15]. However, the identification of the etiological agent, the reservoir, and the epidemiology
of the disease was not unraveled until the second half of the 19th century, when the British
government decided to find a solution for their troops stationed on the island of Malta that
annually suffered substantial losses caused by the so-called “Malta fever.” In 1859, British
Army surgeon Jeffery Marston contracted what he called “Mediterranean remittent fever”
[16]. After recovering, he described his own case in great detail, being the first author to clini-
cally and pathologically differentiate human brucellosis from typhus, typhoid, and other preva-
lent fevers [15]. In 1884, the Australian-born British physician David Bruce was deployed to
Malta to investigate the cause of “Malta fever” (later called brucellosis in his honor). Late in
1886, using a microscope, he observed a great number of micrococci in a fresh preparation of
the splenic pulp of soldiers who had died from the disease [17]. One year later, Sir Bruce iso-
lated the causative agent of “Malta fever” (which he called Micrococcus melitensis and then
renamed Brucella melitensis) from samples of spleens of 4 patients inoculated into Koch’s
nutrient agar and was able to reproduce the disease in monkeys following Koch’s postulates
[18]. A few years later, Professor Almroth Edward Wright developed a serum agglutination
test and demonstrated the presence of specific agglutinins in the blood of infected patients,
which helped differentiate those who suffered “brucellosis” from those with typhoid (cholera)
or malarial fever [19]. The use of this serological test in goats provided the first insights into the
epidemiology of the disease. In 1904, a Public Health Officer of Malta discovered that the blood
of goats that supplied milk to people that had contracted “Malta fever” had agglutinins against
M. melitensis, and a posterior survey indicated that around 50% of Malta’s goats’ blood reacted
to this microorganism. This observation suggested that goats were susceptible to natural infec-
tion with M. melitensis. Based on all knowledge available on brucellosis, the Greek physician
Themistokles Zammit hypothesized that goats were susceptible to Malta fever and that the dis-
ease spread from goats to human. To test his hypothesis, Zammit fed seronegative, healthy
goats with agar cultures of M. melitensis mixed into their food. Goats became seropositive to M.
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melitensis after 20 days or more, and Brucella was isolated from the milk, blood, and urine of
infected animals without any clinical manifestation of the disease [20]. This simple assay dem-
onstrated that goat milk was the disseminating vehicle of the bacteria, rather than an insect vec-
tor, and helped to build the epidemiological link of “Malta fever” to the consumption of this
product. This observation was further confirmed after its ban from the diet of the Malta garri-
son significantly reduced the incidence of brucellosis in the army and naval forces compared to
the general population of Malta that continued to consume contaminated dairy products. Later
on, in 1918, Alice Evans demonstrated the similar characteristics between the M. melitensis and
the etiological agent of bovine epizootic abortion, the “abortus bacillus” (now Brucella abortus),
isolated by a Danish veterinarian Bernhard Bang in 1896, and based on that, both agents were
included under the same bacterial genus (Brucella) in honor of David Bruce, in 1920. Major
events of caprine brucellosis and its relationship with public health throughout history are sum-
marized in Table 1.
World distribution
Caprine brucellosis refers to goat herds infected with B. melitensis. Goats can be susceptible
to B. abortus infection [22,23,24] under particular epidemiological situations (for instance,
when goats live in close contact with B. abortus-infected cattle); however, these individuals
don’t sustain the infection in the herd. Similarly, B. suis isolations from goats have seldom
been reported, but in recent times, they have not been further documented [25]. B. melitensis
comprises 3 biovars (1–3), distinguished solely by their immunochemical reactions with
monospecific anti-lipopolysaccharide (LPS) A- and M-determinant sera [26,27]. Available
information indicates that most infections are caused by biovars 1 and 3 [28], both of which
seem to have similar virulence for goats and humans.
Prevalence of caprine brucellosis around the world has been reported and referenced by
others [28,29,30,31,32]. The disease is present in 5 out of the 7 continents (South and North
America, Europe, Asia, and Africa). Despite being under control in most industrialized coun-
tries, it remains a major problem in the Mediterranean region, the Middle East, Central and
Southeast Asia, sub-Saharan Africa, and parts of Latin America (Fig 1).
As expected, prevalence of human brucellosis is also high in those regions where goat bru-
cellosis occurs [6]. The disease has been historically underreported, probably because low-
income countries prioritize other diseases or lack facilities, human capabilities, and/or specific
Table 1. Dates and major events associated with caprine brucellosis and its relationship with public health throughout history.
When Who What Reference
9th to 7th
centuries B.C.
Neolithic population Initial domestication of goats in the Fertile Crescent (Asia), evidence for the milking of
goats
[11]
400 B.C. Hippocrates II First clinical description of human brucellosis [14]
79 N/A Human skeletons with arthritic condition consistent with brucellosis [7]
1859 Jeffery Marston First author to differentiate human brucellosis from other prevalent fevers [16]
1887 David Bruce Isolated the causative agent of “Malta fever” (Micrococcus melitensis) for the first time
and reproduced the disease in monkeys
[18]
1904 Anonymous Public Health
Officer of Malta
Found agglutinins against M. melitensis in Maltese goats’ blood [20]
1905 Themistokles Zammit Identified Maltese goats’ milk as the source of infection for human brucellosis [20]
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tests that would otherwise underpin diagnoses and research. Over the last 15 years, the infec-
tion has re-emerged, in particular in Eastern Europe, the Balkans, and Eurasia [2]. Table 2
shows those countries where caprine brucellosis (i.e., presence of anti-Brucella antibodies, B.
melitensis isolation, or Brucella DNA detection from goat samples) or brucellosis in humans,
sheep, or cattle due to B. melitensis infection have been reported in recent years (2005–pres-
ent). Historically, B. melitensis biovar 1 is predominant in Latin America [28,33], while biovar
2 is predominant in the Middle East together with biovar 3, which is also more common in
European and African Mediterranean countries, Eurasia, and China [2,28,31,34,35]; biovars 1
and 3 seem to be equally present in India [36,37]. Unfortunately, there are few studies address-
ing the characterization of isolates from sub-Saharan countries.
In the Americas, Brucella melitensis was most likely introduced around the 16th century via
the infected goats and sheep of Spanish and Portuguese conquerors [11]. Today, B. melitensis
is endemic in some regions of Mexico, Peru, and Argentina [28] and has also been reported in
Ecuador and Venezuela [41,48]. Caprine brucellosis is apparently absent in Central America,
Bolivia, Paraguay, and Brazil, although this epidemiological situation is not confirmed [129].
Goat herds from the USA, Canada, Colombia, Chile, and Uruguay are free from B. melitensis
infection, and human cases in these countries are clearly associated with international travelers
or infected food imported from endemic regions [6].
Despite intense joint efforts to eliminate B. melitensis from goat flocks in Europe, the dis-
ease still occurs in Portugal, Spain, France, Italy, the Balkans, Bulgaria, and Greece. Northern
and Central European countries like the United Kingdom, Belgium, the Netherlands, Den-
mark, Germany, Austria, Switzerland, the Czech Republic, Hungary, Poland, Romania, Swe-
den, Norway, and Finland, among others, are officially free of the disease [129].
Fig 1. Caprine brucellosis worldwide distribution. Countries colored in blue indicate those countries where goats, human, cattle, or sheep brucellosis due
to B. melitensis infection have been reported in recent years (2005–present). Countries in grey indicate that the disease is not present or that the status of the
disease is unknown. The list of the countries is detailed in Table 2. The countries were colored using Adobe Illustrator CS6 software. Base map credit: https://
en.wikipedia.org/wiki/World_map#/media/File:BlankMap-World-162E-flat.svg.
https://doi.org/10.1371/journal.pntd.0005692.g001
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Table 2. Countries where caprine brucellosis or brucellosis in humans, sheep, or cattle due to B. melitensis infection have been reported in recent
years (2005–present).
Country Level of detection Reference
America
Argentina Anti-Brucella Ab in goats; isolation of B. melitensis bv1 from goats [38,39,40]
Bolivia and Brazil Mentioned as countries with endemic caprine brucellosis [28]
Ecuador Anti-Brucella Ab in goats; Brucella spp. DNA detection in goat milk and LN [41]
Mexico Anti-Brucella Ab in goats; isolation of B. melitensis from goats [42,43,44]
Paraguay Human case of brucellosis by contact with infected goats: clinical and
serological evidence
[45]
Peru Anti-Brucella Ab in goats [46,47]
Venezuela Anti-Brucella Ab in goats [48]
Europe
Bosnia-Herzegovina Anti-Brucella Ab in goats and human [49,50]
Bulgaria Anti-Brucella Ab in goats and human [51,52]
Croatia Anti-Brucella Ab and isolation of B. melitensis bv3 from goats [53]
France Anti-Brucella Ab in goats; isolation of B. melitensis bv3 from wild goats [54]
Greece Anti-Brucella Ab in goats and human; isolation of B. melitensis bv3 from
human
[55]
Italy Isolation of B. melitensis bv1 and bv3 from goats [56,57]
Macedonia Anti-Brucella Ab in goats [58,59]
Portugal Anti-Brucella Ab in goats [60]
Serbia Anti-Brucella Ab in goats and human [61]
Spain Anti-Brucella Ab in goats [62]
Andorra, Albania, Montenegro, and Cyprus Mentioned as countries with endemic caprine brucellosis [28]
Asia
Afghanistan Anti-Brucella Ab in goats and sheep [63]
Armenia Anti-Brucella Ab in goats [64]
Azerbaijan Anti-Brucella Ab in goats and sheep [65]
Bangladesh Anti-Brucella Ab in goats and sheep [66]
China Isolation of B. melitensis; Anti-Brucella Ab in human [35,67]
Georgia Anti-Brucella Ab in goats; isolation of B. melitensis from goats, sheep and
cattle
[68,69]
India Anti-Brucella Ab in goats and sheep; isolation of B. melitensis bv3 from
goats
[37,70]
Iran Anti-Brucella Ab in goats and sheep; isolation of B. melitensis bv1 and 2
from sheep and human
[71,72,73]
Iraq Anti-Brucella Ab in sheep and isolation of B. melitensis from human [74,75]
Israel Anti-Brucella Ab in goats and human; isolation of B. melitensis bv1 and 2
from goats
[76]
Jordan Anti-Brucella Ab in goats and isolation of B. melitensis bv3 from goat fetus
and vaginal fluid
[77,78]
Kazakhstan Anti-Brucella Ab in goats and sheep; isolation of B. melitensis from blood of
sheep
[79,80,81]
Kuwait Isolation of B. melitensis bv2 from aborted bovine fetus [82]
Kyrgyz Republic and Uzbekistan Anti-Brucella Ab in goats and sheep [80]
Lao Anti-Brucella Ab in goats [83]
Malaysia Isolation of B. melitensis from vaginal fluid and spleen of goats [84]
Mongolia Anti-Brucella Ab in goats and sheep [85]
Nepal Anti-Brucella Ab in goats [86,87]
Pakistan Anti-Brucella Ab in goats [88,89]
Palestine Anti-Brucella Ab in goats; DNA detection and isolation of B. melitensis bv3
from goat milk and fetus
[90,91]
Russia Anti-Brucella Ab in goats and sheep; isolation of B. melitensis bv3 from
goats
[92]
Saudi Arabia Anti-Brucella Ab in goats and sheep [93]
Syria Anti-Brucella Ab and isolation of Brucella spp. in sheep [94]
Tajikistan Anti-Brucella Ab in goats and sheep [95]
Thailand Anti-Brucella Ab in goats and sheep [96,97]
Turkey Anti-Brucella Ab in goats and human; isolation of B. melitensis from goats [98,99]
UAE Anti-Brucella Ab in goats, sheep and camels [100,101]
(Continued)
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In Asia, brucellosis is broadly distributed. Except for Japan and the Republic of Korea
(South Korea), where the disease has never been reported, caprine brucellosis is officially rec-
ognized in several countries on the continent, such as Turkey, Israel, Jordan, Iraq, Iran, Arme-
nia, Georgia, Afghanistan, Russia, and Mongolia, among others (see references in Table 2),
and is also known to be endemic in countries like Syria, Lebanon, India, China, Indonesia,
Myanmar, etc., where no public information is available or the distribution of the information
is restricted [28,29,102,129].
In Africa, caprine brucellosis is endemic in Mediterranean countries like Morocco, Algeria,
Tunisia, Libya, and Egypt, and also in those countries located in the eastern part of the conti-
nent, such as Sudan, Eritrea, Ethiopia, Somalia, Kenya, Uganda, and Tanzania (see Table 2 for
references). Unfortunately, there is no information available from Central and West African
countries like Chad, Congo, Angola, Zambia, Cameroon, Mali, Cote d’ Ivoire, Guinea, and
Senegal, among others, where goats are abundant [130]. Altogether, the information above
indicates that the knowledge regarding distribution of caprine brucellosis as well as the pres-
ence of B. melitensis around the world is sparse, especially in some areas of the Americas, Asia
and Africa. The lack of useful epidemiological data must stimulate official veterinary services
and public health officers to collect and share data for designing control and eradication plans.
Economic impact: Direct and indirect cost in human health and goat
production
Since brucellosis is considered a neglected disease that significantly affects countries where
resources are limited, there are only a few studies that measure the economic impact of brucello-
sis in small ruminants. Sulima and Venkataraman (2010) and Singh et al. (2015) estimated the
annual loss in India at Rs. 2,121 per goat (around US$39) and at US$71 million total, respectively
Table 2. (Continued)
Country Level of detection Reference
Lebanon, Bahrein, Qatar, Oman, Yemen, Turkmenistan, Myanmar, Cambodia, Vietnam, Brunei,
Indonesia, Sri Lanka, and Singapore
Mentioned as countries with presence of caprine brucellosis [28,29,31,100,102,103]
Africa
Algeria Anti-Brucella Ab in goats and human; isolation of B. melitensis bv3 from
goats
[104,105]
Egypt Anti-Brucella Ab in goats and sheep; isolation of B. melitensis bv3 from
goats
[106,107]
Ethiopia Anti-Brucella Ab in goats and sheep and isolation of B. melitensis [108,109]
Ghana Anti-Brucella Ab in goats and sheep [110]
Kenya Anti-Brucella Ab in goats and human [111]
Libya Anti-Brucella Ab in goats and human [112]
Morocco Anti-Brucella Ab in goats [113]
Namibia Anti-Brucella Ab in goats [114]
Niger Anti-Brucella Ab in goats and sheep [115]
Nigeria Anti-Brucella Ab in goats [116,117]
Somalia Anti-Brucella Ab in goats and sheep [118]
South Africa Anti-Brucella Ab in goats; isolation of B. melitensis bv1 from human [119]
Sudan Anti-Brucella Ab in goats and sheep; isolation of B. melitensis bv1 from ram [120,121,122]
Tanzania Anti-Brucella Ab in goats [123,124]
Uganda Anti-Brucella Ab in goats and human [125,126]
Zimbabwe Isolation of B. melitensis bv1 from goat [127]
Tunisia, Chad, Cape Verde, Ivory Coast Burkina Faso, Eritrea, Djibouti, Angola, Zambia, Zimbabwe,
and Swaziland
Mentioned as countries with presence of caprine brucellosis [28,30,32,128]
Abbreviations: Ab, antibodies; bv, biovar
https://doi.org/10.1371/journal.pntd.0005692.t002
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[131,132]. Brisibe et al. (1996) calculated a loss of US$3.2 million per annum in 2 states of Nigeria
[133], and more recently, Bamaiyi et al. (2015) reported the annual economic impact in Malaysia
due to caprine brucellosis at almost US$2.6 million [134]. However, every publication utilizes dif-
ferent criteria, which makes comparisons difficult. A simple analysis of economic impact of cap-
rine brucellosis on meat goat farmers can be calculated by taking into consideration the culling of
animals serologically positive for Brucella, the abortions and stillbirths, the cost of veterinary ser-
vices, and miscellaneous factors arising from brucellosis on farms. The economic loss for culling
1 reactor animal is equal to the market price of a healthy goat purchased for its replacement,
minus the amount perceived for selling the positive reactor to a slaughterhouse. An abortion or
stillbirth must be considered as loss of profit and its value calculated as the market value of a
6-month-old kid (which weighs around 10 kg). Veterinary services include visits to the farm, pro-
fessional assistance, and serological surveys, while miscellaneous factors—such as man hours for
taking care of ill flocks, reduced weight gain, the increased morbidity of weak offspring and low
birth weight kids, any interest paid on money borrowed from banks, etc.—are variable and,
therefore, difficult to predict and calculate. Based on these premises, it is possible to roughly esti-
mate the economic impact of a brucellosis outbreak in a meat goat herd. For instance, in Argen-
tina, the impact of a brucellosis outbreak in a flock of 100 goats, in which 25 does abort and 10
others become serologically positive, would be:
A) Replacement of animals (healthy female Creole crossbreed 1-year-old): US$50 each × 35
does = US$1,750
B) Culled animals: US$20 × 35 goats = US$700
C) Six-month-old kids: US$30 each x 25 goats = US$750
D) Veterinary assistance: US$200 (every farm visit)
E) Individual serological tests: US$4 (includes disposables and 1 serological test [Rose Bengal
or Fluorescent Polarization assay]) × 100 animals × 2 (2 rounds of survey minimum) =
US$800
Economic impact ¼ US$ ½ðA   BÞ þ Cþ Dþ E
¼ US$ ½ð1; 750   700Þ þ 750þ 200þ 800
¼ US$2; 800
There are some differences if the analysis is done for a dairy goat farm. For instance, the
market price of healthy milking goats (Anglo Nubian, Saanen, Toggenburg) is higher than for
meat goats, and the loss of milk yield due to culled does has to be taken into account as well.
Thus, a conservative impact of a brucellosis outbreak in a herd of 100 milk goats, in which 25
does abort and 10 others become serologically positive, would be:
A) Replacement of animals (healthy 1-year-old female): US$100 × 35 does = US$3,500
B) Culled animals: US$20 × 35 goats = US$700
C) Lower milk yield: US$4/L of milk farm sale × 500 L/lactation period × 35 culled
animals = US$70,000
D) Veterinary assistance: US$200 (every farm visit) × 3 = US$600
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E) Individual serological tests: US$4 (include disposables and 1 serological test [Rose Bengal
or Fluorescent Polarization assay]) × 100 animals × 3 (3 rounds of survey minimum) =
US$1,200
Economic impact ¼ US$ ½ðA   BÞ þ Cþ Dþ E
¼ US$ ½ð3; 500   700Þ þ 70; 000þ 600þ 1; 200
¼ US$74; 600
The estimated cost will vary with the location, production system, facilities, and miscella-
neous factors included. The calculations need to include additional losses due to the socioeco-
nomic and indirect health effects of the disease in humans. Still today, human brucellosis is an
underreported disease, often mistaken for malaria and typhoid fever (Halliday et al., 2015).
WHO estimates around 500,000 new cases reported and an equal number of nonreported
cases of human brucellosis each year, a high proportion of them caused by B. melitensis. Vul-
nerable populations include not only dairy goat and sheep farmers, small ruminant ranchers
(especially in marginalized goat-keeping communities), and veterinarians and abattoir work-
ers, but also lab personnel and consumers of unpasteurized dairy products.
Economic losses caused by the disease in humans arise from the cost of hospital treatment,
medicines, patient out-of-pocket treatment expenses, and loss of work days and income due to
illness. In Spain, losses by brucellosis were estimated at 790,000 pesetas per patient (US$5,030)
[135], while in New Zealand, the approximated cost per patient was NZ$3,200 (US$2,250)
[136]. In Africa, the cost of treating a patient ranges from 9 EUR in Tanzania to 200 EUR in
Morocco and as much as 650 EUR in Algeria [128]. In Argentina, the annual treatment cost of
brucellosis was estimated to be US$4,000 [137].
Traditional recommended antibiotic treatment for human brucellosis consists of 100 mg of
doxycycline twice a day per os for 45 days combined with 1 g of streptomycin daily intramus-
cular (IM), 15 to 21 days; gentamycin 5 mg/kg/day (300–350 mg) IM, 7 to 10 days; or, alterna-
tively, rifampicin 15mg/kg/day (600–900 mg) per os for 45 days [3]. Today, in Argentina, the
cost for antibiotic treatment for a single patient is approximately US$200–US$300. This value
does not include lost profit, laboratory analysis and X-ray images, medical expenses, and other
miscellaneous expenses. Considering a complete health treatment, the cost for every brucello-
sis-infected person is up to US$1,000.
Conclusions and future approaches
Brucellosis in small ruminants remains a significant burden on animal and human health
in the developing world. Small ruminant owners and governments where brucellosis is
endemic do not usually have enough economic resources nor technical expertise or facili-
ties to afford control or eradication campaigns. On the other hand, B. melitensis is the Bru-
cella species with the highest zoonotic potential, and in humans, it frequently presents
nonspecific clinical symptoms similar to other infectious diseases that are also present in
brucellosis-endemic areas [138]. Thus, the challenge of clinical–differential diagnosis adds
to the inequality of accessible healthcare facilities in most developing countries. These
cumulative issues contribute to brucellosis remaining endemic and neglected in resource-
limited regions of the world.
The future major challenges include developing a more effective and affordable DIVA (dif-
ferentiating infected from vaccinated animals) vaccine against small ruminant brucellosis for
massive protection in endemic areas. Undoubtedly, this goal must be accompanied by an inte-
grated control strategy with a massive vaccination campaign, strict epidemiological surveillance,
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and controlled movement of animals. Meanwhile, current efforts must focus on controlling
new outbreaks using available tools to prevent B. melitensis transmission to humans.
Acknowledgments
The authors want to thank to Dr. L. Garry Adams for his critical review and thoughtful sugges-
tions on the manuscript and Mr. Matias Ottaviani for helping us with the illustration.
Key learning points
• Brucella melitensis is the etiological agent of caprine brucellosis and the species of the
Brucella genus with the highest zoonotic potential.
• Lesions in vertebral bodies consistent with brucellosis were found in an Australopithe-
cus africanus, an ancient human who lived 2.5 million years ago.
• The disease remains a significant burden on goats and human health in the Mediterra-
nean region, the Middle East, Central and Southeast Asia (including India and China),
sub-Saharan Africa, and parts of Latin America.
• B. melitensis comprises 3 biovars (1–3): biovar 1 is predominant in Latin America, bio-
var 2 is predominant in the Middle East, and biovar 3 is also present in Middle East
and also in European and African Mediterranean countries, Eurasia, and China. Bio-
vars 1 and 3 seem to be equally present in India.
• The economic impact of a brucellosis outbreak is higher in milk- than in meat-produc-
ing farms.
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47. Toledo M, Delgado A, Suárez F, Noé N. Prevalencia de brucelosis caprina en tres distritos de la pro-
vincia de Cañete, Lima. Rev Inv Vet Peru. 2007; 18: 136–140.
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005692 August 17, 2017 12 / 17
48. Javitt J. M, Paez Z, Duran J, Melendez I. Seroprevalencia de la brucelosis en pequeños rumiantes.
Municipio Torres. Año 2008. REDVET Rev Electr Vet Spain. 2009. Veterinaria Organizacion.
49. Nedic DN, Mehmedbasic Z, Hadzovic D, Trkulija R. Implementation of disease control measures for
brucellosis of small ruminants in Bosnia and Herzegovina for the period January 2009-December
2010 In: Microbiologı́a AAd, editor. Brucellosis 2011 International Research Conference. Buenos
Aires, Argentina. 2011. pp. 140 pp.
50. Obradovic Z, Velic R. Epidemiological characteristics of brucellosis in Federation of Bosnia and Herze-
govina. Croat Med J. 2010; 51: 345–350. https://doi.org/10.3325/cmj.2010.51.345 PMID: 20718088
51. Likov B, Nenova-Poliakova R, Tomova I, Kamenov P, Boikovski I, et al. Epidemiological characteris-
tics of brucellosis in sheep and goats in Bulgaria: 2005–2008. Prilozi. 2010; 31: 55–64. PMID:
20703183
52. Nenova R, Tomova I, Saparevska R, Kantardjiev T. A new outbreak of brucellosis in Bulgaria detected
in July 2015—preliminary report. Euro Surveill. 2015; 20 (39) pii:30031.
53. Spicic S, Zdelar-Tuk M, Racic I, Duvnjak S, Cvetnic Z. Serological, bacteriological, and molecular
diagnosis of brucellosis in domestic animals in Croatia. Croat Med J. 2010; 51: 320–326. https://doi.
org/10.3325/cmj.2010.51.320 PMID: 20718085
54. Mick V, Le Carrou G, Corde Y, Game Y, Jay M, et al. Brucella melitensis in France: persistence in wild-
life and probable spillover from Alpine ibex to domestic animals. PLoS ONE. 2014; 9: e94168. https://
doi.org/10.1371/journal.pone.0094168 PMID: 24732322
55. Karagiannis I, Mellou K, Dougas G, Theocharopoulos G, Vourvidis D, et al. Outbreak investigation of
brucellosis in Thassos, Greece, 2008. Euro Surveill. 2012; 17: pii = 20116.
56. De Massis F, Ancora M, Atzeni M, Rolesu S, Bandino E, et al. MLVA as an Epidemiological Tool To
Trace Back Brucella melitensis Biovar 1 Re-Emergence in Italy. Transbound Emerg Dis. 2015; 62:
463–469. https://doi.org/10.1111/tbed.12397 PMID: 26194658
57. Di Giannatale E, De Massis F, Ancora M, Zilli K, Alessiani A. Typing of Brucella field strains isolated
from livestock populations in Italy between 2001 and 2006. Vet Ital. 2008; 44: 383–388. PMID:
20405440
58. Naletoski I, Kirandziski T, Mitrov D, Krstevski K, Dzadzovski I, et al. Gaps in brucellosis eradication
campaign in sheep and goats in Republic of Macedonia: lessons learned. Croat Med J. 2010; 51:
351–356. https://doi.org/10.3325/cmj.2010.51.351 PMID: 20718089
59. Kirandjiski T, Nikolovska G, Nakova E, Smilenovska B, Strojmanovska B, et al. Brucellosis control in
small ruminants in the Republic of Macedonia. Prilozi. 2010; 31: 181–190. PMID: 20703191
60. Coelho AM, Coelho AC, Rodrigues J. Seroprevalence and sheep and goat brucellosis on the north-
east of Portugal. Arch Med Vet. 2013; 45: 167–172.
61. Markovic-Denic L, Trifunovic VS, Zugic V, Radojic D, Stevanovic. The first outbreak of brucellosis in
the region of Sabac. Vojnosanit Pregl. 2010; 67: 634–637. PMID: 20845665
62. Alvarez J, Saez JL, Garcia N, Serrat C, Perez-Sancho M, et al. Management of an outbreak of brucel-
losis due to B. melitensis in dairy cattle in Spain. Res Vet Sci. 2011; 90: 208–211. https://doi.org/10.
1016/j.rvsc.2010.05.028 PMID: 20579679
63. Hussain A, Ghulam Z, Rasuli AB, Schauwers W, Dennison T, et al. Seroprevalence survey of animal
brucellosis in Afghanistan. In: Assessment FIfR, editor. Brucellosis 2014 International Research Con-
ference. Berlin, Germany. 2014; pp. 226 pp.
64. Porphyre T, Jackson R, Sauter-Louis C, Ward D, Baghyan G, et al. Mapping brucellosis risk in com-
munities in the Republic of Armenia. Geospatial Health. 2010; 5: 103–118. https://doi.org/10.4081/gh.
2010.191 PMID: 21080325
65. Omarov AM, Jackson R, Brant J, Rush T, Maes E. The new brucellosis surveillance system in Azer-
baijan. In: Microbiologia AAd, editor. Brucellosis 2011 International Research Conference. Buenos
Aires, Argentina. 2011; pp. 140 pp.
66. Islam MA, Khatun MM, Werre SR, Sriranganathan N, Boyle SM. A review of Brucella seroprevalence
among humans and animals in Bangladesh with special emphasis on epidemiology, risk factors and
control opportunities. Vet Microbiol. 2013; 166: 317–326. https://doi.org/10.1016/j.vetmic.2013.06.
014 PMID: 23867082
67. Li YJ, Li XL, Liang S, Fang LQ, Cao WC. Epidemiological features and risk factors associated with the
spatial and temporal distribution of human brucellosis in China. BMC Infect Dis. 2013; 13: 547. https://
doi.org/10.1186/1471-2334-13-547 PMID: 24238301
68. Duran-Ferrer M, Avaliani L, Chumburidze K, Pacios A, ElIdrissi A, et al. Assessment of brucellosis epi-
demiology in theRepublic of Georgia and proposal of sustainable prevention and control In: Assess-
ment FIfR, editor. Brucellosis 2014 International Research Conference. Berlin, Germany.
2014; pp. 226 pp.
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005692 August 17, 2017 13 / 17
69. Mamisashvili E, Kracalik IT, Onashvili T, Kerdzevadze L, Goginashvili K, et al. Seroprevalence of bru-
cellosis in livestock within three endemic regions of the country of Georgia. Prev Vet Med. 2013; 110:
554–557. https://doi.org/10.1016/j.prevetmed.2012.12.005 PMID: 23287714
70. Sadhu DB, Panchasara HH, Chauhan HC, Sutariya DR, Parmar VL, et al. Seroprevalence and com-
parison of different serological tests for brucellosis detection in small ruminants. Vet World. 2015; 8:
561–566. https://doi.org/10.14202/vetworld.2015.561-566 PMID: 27047135
71. Akbarmehr J, Ghiyamirad M. Serological survey of brucellosis in livestock animals in Sarab City (East
Azarbayjan province), Iran. African J Microbiol Res. 2011; 5: 1220–1223.
72. Pishva E, Salehi R, Hoseini A, Kargar A, Taba FE, et al. Molecular typing of Brucella species isolates
from Human and livestock bloods in Isfahan province. Adv Biomed Res. 2015; 4: 104. https://doi.org/
10.4103/2277-9175.157798 PMID: 26261806
73. Ebrahimi A, Milan JS, Mahzoonieh MR, Khaksar K. Shedding Rates and SeroPrevalence of Brucella
melitensis in Lactating Goats of Shahrekord, Iran. Jundishapur J Microbiol. 2014; 7: e9394. https://
doi.org/10.5812/jjm.9394 PMID: 25147691
74. Al-Tae AH, Al-Samarrae EA. Detection of Brucella antibodies of sheep in Al-Anbar province by using
some serological tests. Iraqi J Vet Med. 2013; 37: 7–12.
75. Bechtol D, Carpenter LR, Mosites E, Smalley D, Dunn JR. Brucella melitensis infection following mili-
tary duty in Iraq. Zoonoses Public Health. 2011; 58: 489–492. https://doi.org/10.1111/j.1863-2378.
2011.01399.x PMID: 21824352
76. Armon L, Hadani Y, Chechik C, Bardenstein S. Large human Brucella melitensis outbreak in Israel,
2014. Israel J Vet Med. 2015; 70: 63–65.
77. Samadi A, Ababneh MM, Giadinis ND, Lafi SQ. Ovine and Caprine Brucellosis (Brucella melitensis) in
Aborted Animals in Jordanian Sheep and Goat Flocks. Vet Med Int. 2010; 2010: 458695. https://doi.
org/10.4061/2010/458695 PMID: 21052561
78. Al-Majali AM. Seroepidemiology of caprine brucellosis in Jordan. Small Rum Res. 2005; 58: 13–18.
79. Karibayev T, Sytnik I, Tyulegenov S, Seidakhmetova R, Jailbekova A, et al. Role of agricultural ani-
mals in brucellosis transmission in southern Kazakhstan. In: Assessment FIfR, editor. Brucellosis
2014 International Research Conference. Berlin, Germany. 2014; pp. 226 pp.
80. Wolfram JH, Butaev MK, Duysheev A, Gabbasova AR, Khasanov OS, et al. Epidemiology chapter.
Vaccine. 2010; 28 Suppl 5: F77–84.
81. Shevtsov A, Ramanculov E, Shevtsova E, Kairzhanova A, Tarlykov P, et al. Genetic diversity of Bru-
cella abortus and Brucella melitensis in Kazakhstan using MLVA-16. Infect Genet Evol. 2015; 34:
173–180. https://doi.org/10.1016/j.meegid.2015.07.008 PMID: 26160544
82. El Bayoumy I, Azmi H. Study of epidemiological features of Brucellosis in Kuwait. Global Res J Pub
Health Epidemiol. 2014; 1: 23–30.
83. Douangngeun B, Theppangna W, Soukvilay V, Senaphanh C, Phithacthep K, et al. Seroprevalence of
Q Fever, Brucellosis, and Bluetongue in Selected Provinces in Lao People’s Democratic Republic. Am
J Trop Med Hyg. 2016; 95: 558–561. https://doi.org/10.4269/ajtmh.15-0913 PMID: 27430548
84. Bamaiyi PH, Hassan L, Khairani-Bejo S, Zainal Abidin M, Ramlan M, et al. Isolation and molecular
characterization of Brucella melitensis from seropositive goats in Peninsula Malaysia. Trop Biomed.
2012; 29: 513–518. PMID: 23202595
85. Zolzaya B, Selenge T, Narangarav T, Gantsetseg D, Erdenechimeg D, et al. Representative seroprev-
alences of human and livestock brucellosis in two Mongolian provinces. Ecohealth. 2014; 11: 356–
371. https://doi.org/10.1007/s10393-014-0962-7 PMID: 25012215
86. Bindari YR, Shrestha S. Seroprevalence of brucellosis and risk factors assessment in caprines of
Ramechhap District In: Assessment FIfR, editor. Brucellosis 2014 International Research Conference.
Berlin, Germany. 2014; pp. 226 pp.
87. Pandeya YR, Joshi DD, Dhakal S, Ghimire L, Mahato BR, et al. Seroprevalence of brucellosis in differ-
ent animal species of Kailali district, Nepal. Intern J Infect Microbiol. 2013; 2: 22–25.
88. Din AMU, Khan SA, Ahmad I, Rind R, Hussain T, et al. A study on the seroprevalence of brucellosis in
human and goat populations of district Bhimber, Azad Jammu and Kashmir. J Anim Plant Sci. 2013;
23: 113–118.
89. Arshad M, Munir M, Khan HJI, Abbas RZ, Rasool MH, et al. Seroprevalence of brucellosis in goats
from public and private livestock farms in Pakistan. J Vet Res. 2011; 15: 297–304.
90. Awwad E, Farraj MA, Adwan K, Essawi TA. Isolation, identification and molecular characterization of
Brucella strains isolated from small ruminants in the West Bank, Palestine. Revue Med Vet. 2011;
162: 236–239.
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005692 August 17, 2017 14 / 17
91. Hawari AD. Epidemiological studies, seroprevalance and some risk factors of brucellosis in sheep and
goats in the South Province of West Bank. Asian J Anim Vet Adv. 2012; 7: 535–539.
92. Kulakov YK, Novikova MD, Sklyarov OD. Epidemiological status of brucellosis in the Russian Federa-
tion. In: Assessment FIfR, editor. Brucellosis 2014 International Research Conference. Berlin, Ger-
many. 2014; pp. 226 pp.
93. Kandeel AE, Gamal TM, Sediek AA, Salauddin HS, Fadlelmoula AA. Seroprevalence of Brucellosis
within sheep and goat flocks in Alkamil province in Saudi Arabia. Bothalia J. 2014; 44: 131–140.
94. Al-Mariri A, Ramadan L, Akel R. Assessment of milk ring test and some serological tests in the detec-
tion of Brucella melitensis in Syrian female sheep. Trop Anim Health Prod. 2011; 43: 865–870. https://
doi.org/10.1007/s11250-010-9774-0 PMID: 21234678
95. Rajala EL, Grahn C, Ljung I, Sattorov N, Boqvist S, et al. Prevalence and risk factors for Brucella sero-
positivity among sheep and goats in a peri-urban region of Tajikistan. Trop Anim Health Prod. 2016;
48: 553–558. https://doi.org/10.1007/s11250-015-0992-3 PMID: 26779709
96. Ekgatat M, Tiensin T, Kanitpun R, Buamithup N, Jenpanich C, et al. Brucellosis control and eradication
programme in Thailand. Preliminary evaluation of the epidemioloical situation in cattle, buffaloes and
sheep and goats. In: Microbiologia AAd, editor. Brucellosis 2011 International Research Conference.
Buenos Aires, Argentina. 2011; pp. 140 pp.
97. Te-Chaniyoma T, Geatera AF, Kongkaewc W, Chethanondb U, Chongsuvivatwong V. Goat farm
management and Brucella serological test among goat keepers and livestock officers, 2011–2012,
Nakhon Si Thammarat Province, southern Thailand. One Health. 2016; 2: 126–130. https://doi.org/
10.1016/j.onehlt.2016.08.001 PMID: 28616486
98. Yumuk Z, O’Callaghan D. Brucellosis in Turkey—an overview. Int J Infect Dis. 2012; 16: e228–235.
https://doi.org/10.1016/j.ijid.2011.12.011 PMID: 22333223
99. Erdenlig S, Baklan EA, Saytekin AM, Saglam G, Karagul MS. The identification of Brucella strains iso-
lated during mass vaccination campaign with B. melitensis Rev1 and B. abortus S19 vaccines in Tur-
key In: Assessment FIfR, editor. Brucellosis 2014 International Research Conference. Berlin,
Germany. 2014. pp. 226 pp.
100. Gul ST, Khan A. Epidemiology and epizootology of brucellosis: A review Pakistan Vet J. 2007; 27:
145–151.
101. Mohammed MA, Shigidy MT, Al Juboori AY. Sero-prevalence and epidemiology of brucellosis in cam-
els, sheep and goats in Abu Dhabi Emirate. Int J Anim Vet Adv. 2013; 5: 82–86.
102. Bamaiyi PH, Hassan L, Khairani-Bejo S, Zainal AM. Updates on brucellosis in Malaysia and Southeast
Asia. Malaysian J Vet Res. 2014; 5: 71–82.
103. El Tahir YEH, Nair RR. Prevalence of brucellosis in the Sultanate of Oman with reference to some Mid-
dle-East countries. Vet Res. 2011; 4: 71–76.
104. Lounes N, Bouyoucef A, Garin-Bastuji B. Bovine and caprine brucellosis in the central region of Alge-
ria. In: Microbiologia AAd, editor. Brucellosis 2011 International Research Conference. Buenos Aires,
Argentina. 2011; pp. 140 pp.
105. Gabli A, Agabou A, Gabli Z. Brucellosis in nomadic pastoralists and their goats in two provinces of the
eastern Algerian high plateaus. Trop Anim Health Prod. 2015; 47: 1043–1048. https://doi.org/10.
1007/s11250-015-0825-4 PMID: 25877260
106. Hegazy YM, Moawad A, Osman S, Ridler A, Guitian J. Ruminant brucellosis in the Kafr El Sheikh Gov-
ernorate of the Nile Delta, Egypt: prevalence of a neglected zoonosis. PLoS Negl Trop Dis. 2011; 5:
e944. https://doi.org/10.1371/journal.pntd.0000944 PMID: 21264355
107. Wareth G, Melzer F, Elschner MC, Neubauer H, Roesler U. Detection of Brucella melitensis in bovine
milk and milk products from apparently healthy animals in Egypt by real-time PCR. J Infect Dev Ctries.
2014; 8: 1339–1343. https://doi.org/10.3855/jidc.4847 PMID: 25313613
108. Asmare K, Megersa B, Denbarga Y, Abebe G, Taye A, et al. A study on seroprevalence of caprine bru-
cellosis under three livestock production systems in southern and central Ethiopia. Trop Anim Health
Prod. 2013; 45: 555–560. https://doi.org/10.1007/s11250-012-0258-2 PMID: 22961233
109. Sintayehu G, Melesse B, Abayneh D, Sintayehu A, Melaku S, et al. Epidemiological survey of brucello-
sis in sheep and goats in selected pastoral and agro-pastoral lowlands of Ethiopia. Rev Sci Tech.
2015; 34: 881–893. PMID: 27044159
110. Jarikre TA, Emikpe BO, Folitse RD, Odoom TK, Fuseini A, et al. Prevalence of brucellosis in small
ruminants in three regions of Ghana. Bulgarian J Vet Med. 2015; 18: 49–55.
111. Osoro EM, Munyua P, Omulo S, Ogola E, Ade F, et al. Strong Association Between Human and Ani-
mal Brucella Seropositivity in a Linked Study in Kenya, 2012–2013. Am J Trop Med Hyg. 2015; 93:
224–231. https://doi.org/10.4269/ajtmh.15-0113 PMID: 26101275
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005692 August 17, 2017 15 / 17
112. Ahmed MO, Elmeshri SE, Abuzweda AR, Blauo M, Abouzeed YM, et al. Seroprevalence of brucellosis
in animals and human populations in the western mountains region in Libya, December 2006-January
2008. Euro Surveill. 2010; 15 (30) pii:19625.
113. Benkirane A, Essamkaoui S, El Idrissi A, Lucchese L, Natale A. A sero-survey of major infectious
causes of abortion in small ruminants in Morocco. Vet Ital. 2015; 51: 25–30. https://doi.org/10.12834/
VetIt.389.1814.1 PMID: 25842210
114. Magwedere K, Bishi A, Tjipura-Zaire G, Eberle G, Hemberger Y, et al. Brucellae through the food
chain: the role of sheep, goats and springbok (Antidorcus marsupialis) as sources of human infections
in Namibia. J S Afr Vet Assoc. 2011; 82: 205–212. PMID: 22616433
115. Boukary AR, Saegerman C, Abatih E, Fretin D, Alambedji Bada R, et al. Seroprevalence and potential
risk factors for Brucella spp. infection in traditional cattle, sheep and goats reared in urban, periurban
and rural areas of Niger. PLoS ONE. 2013; 8: e83175. https://doi.org/10.1371/journal.pone.0083175
PMID: 24358261
116. Ogugua AJ, Akinseye VO, Ayoola MC, Oyesola OO, Shima FK, et al. Seroprevalence and risk factors
of brucellosis in goats in selected states in Nigeria and the public health implications. Afr J Med Med
Sci. 2014; 43: 121–129. PMID: 26689681
117. Kaltungo BY, Saidu SN, Sackey AK, Kazeem HM. Serological evidence of brucellosis in goats in
kaduna north senatorial district of kaduna state, Nigeria. ISRN Vet Sci 2013: 963673. https://doi.org/
10.1155/2013/963673 PMID: 23762594
118. Hassan-Kadle AA. A review on ruminant and human brucellosis in Somalia. Open J Vet Med. 2015; 5:
133–137.
119. Wojno JM, Moodley C, Pienaar J, Beylis N, Jacobsz L, et al. Human brucellosis in South Africa: Public
health and diagnostic pitfalls. S Afr Med J. 2016; 106: 883–885. https://doi.org/10.7196/SAMJ.2016.
v106i9.11020 PMID: 27601111
120. Ahmed SI, Musa MT. Prevalence of Ovine Brucellosis and Isolation of Brucella melitensis biovar 1 in
South Kordofan State, Sudan. Sudan J Vet Res. 2015; 30: 19–23.
121. Musa MT. Caprine Brucellosis under Different Husbandry Systems in Darfur States, Sudan. Sudan J
Vet Res. 2006; 21: 57–66.
122. Zein AM, Adris MA. Seroprevelance of brucellosis in different animals species in northern state
(Sudan). ARPN J Sci Technol. 2015; 5: 210–214.
123. Assenga JA, Matemba LE, Muller SK, Malakalinga JJ, Kazwala RR. Epidemiology of Brucella infection
in the human, livestock and wildlife interface in the Katavi-Rukwa ecosystem, Tanzania. BMC Vet
Res. 2015; 11: 189. https://doi.org/10.1186/s12917-015-0504-8 PMID: 26253151
124. Chota AC, Magwisha HB, Stella B, Bunuma EK, Shirima GM, et al. Prevalence of brucellosis in live-
stock and incidences in humans in east Africa. African Crop Sci J. 2016; 24: 45–52.
125. Grace AK, Jesca N, Acai J, Nyakarahuka L. Investigation of the risk factors to human brucellosis in
Mubende district, Uganda. In: Assessment FIfR, editor. Brucellosis 2014 International Research Con-
ference. Berlin, Germany. 2014; pp. 226 pp.
126. Miller R, Nakavuma JL, Ssajjakambwe P, Vudriko P, Musisi N, et al. The Prevalence of Brucellosis in
Cattle, Goats and Humans in Rural Uganda: A Comparative Study. Transbound Emerg Dis. 2015; 63:
e197–e210. https://doi.org/10.1111/tbed.12332 PMID: 25660343
127. Matope G, Bhebhe E, Muma JB, Skjerve E, Djonne B. Characterization of some Brucella species from
Zimbabwe by biochemical profiling and AMOS-PCR. BMC Res Notes. 2009; 2: 261. https://doi.org/
10.1186/1756-0500-2-261 PMID: 20028545
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